Tekla Healthcare Investors (NYSE:HQH) President Daniel R. Omstead bought 5,000 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was bought at an average price of $21.01 per share, with a total value of $105,050.00. Following the transaction, the president now owns 110,357 shares in the company, valued at $2,318,600.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
HQH stock traded up $0.23 during midday trading on Friday, reaching $21.21. The company had a trading volume of 3,982 shares, compared to its average volume of 224,804. Tekla Healthcare Investors has a 1 year low of $13.78 and a 1 year high of $21.69. The company has a 50 day moving average of $19.74 and a two-hundred day moving average of $20.02.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Friday, May 29th will be given a $0.41 dividend. The ex-dividend date is Thursday, May 28th. This represents a $1.64 dividend on an annualized basis and a yield of 7.73%.
About Tekla Healthcare Investors
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Read More: Compound Interest
Receive News & Ratings for Tekla Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.